Meta-analysis of the correlation between glioma prognosis and PD-1/ PD-L1 expression

被引：0
|
作者：
Ren, Chang-cheng [1 ]
Xu, Bo [1 ]
Wang, Min-shu [1 ]
He, Feng [1 ]
Chen, Jun-hui [1 ]
Liao, Liang [1 ]
Liang, Wu [1 ]
机构：
[1] Hubei Minzu Univ, Dept Neurosurg, Minda Hosp, Enshi 445000, Peoples R China
来源：
ASIAN JOURNAL OF SURGERY | 2023年 / 46卷 / 12期
关键词：
Glioma; Prognosis; PD-1; PD-L1;
D O I：
10.1016/j.asjsur.2023.08.057
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
引用
收藏
页码：5632 / 5634
页数：3
相关论文
共 50 条
  • [21] Regulation of PD-1/PD-L1 pathway and resistance to PD-1/PD-L1 blockade
    Bai, Jie
    Gao, Zhitao
    Li, Xiang
    Dong, Liang
    Han, Weidong
    Nie, Jing
    ONCOTARGET, 2017, 8 (66) : 110693 - 110707
  • [22] Highly Activated PD-1/PD-L1 Pathway in Gastric Cancer with PD-L1 Expression
    Saito, Hiroaki
    Kono, Yusuke
    Murakami, Yuki
    Shishido, Yuji
    Kuroda, Hirohiko
    Matsunaga, Tomoyuki
    Fukumoto, Yoji
    Osaki, Tomohiro
    Ashida, Keigo
    Fujiwara, Yoshiyuki
    ANTICANCER RESEARCH, 2018, 38 (01) : 107 - 112
  • [23] Blocking the PD-1/PD-L1 pathway in glioma: a potential new treatment strategy
    Xue, Song
    Hu, Man
    Iyer, Veena
    Yu, Jinming
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2017, 10
  • [24] Blocking the PD-1/PD-L1 pathway in glioma: a potential new treatment strategy
    Song Xue
    Man Hu
    Veena Iyer
    Jinming Yu
    Journal of Hematology & Oncology, 10
  • [25] Evaluation of PD-L1 biomarker for immune checkpoint inhibitor (PD-1/PD-L1 inhibitors) treatments for urothelial carcinoma patients: A meta-analysis
    Rui, Xin
    Gu, Ting-Ting
    Pan, Hua-Feng
    Zhang, Hui-Zhi
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2019, 67 : 378 - 385
  • [26] PD-L1 expression and EGFR status in advanced non-small-cell lung cancer patients receiving PD-1/PD-L1 inhibitors: a meta-analysis
    Li, Jing
    Gu, Jian
    FUTURE ONCOLOGY, 2019, 15 (14) : 1667 - 1678
  • [27] PD-1/PD-L1 based immunochemotherapy versus chemotherapy alone for advanced esophageal squamous cell carcinoma: A meta-analysis focus on PD-L1 expression level
    Jin, Zixian
    Wang, Jiping
    Sun, Jiajing
    Zhu, Chengchu
    Zhang, Jian
    Zhang, Bo
    CANCER REPORTS, 2023, 6 (07)
  • [28] PD-1/PD-L1 inhibitors
    Sunshine, Joel
    Taube, Janis M.
    CURRENT OPINION IN PHARMACOLOGY, 2015, 23 : 32 - 38
  • [29] PD-1/PD-L1 in disease
    Kuol, Nyanbol
    Stojanovska, Lily
    Nurgali, Kulmira
    Apostolopoulos, Vasso
    IMMUNOTHERAPY, 2018, 10 (02) : 149 - 161
  • [30] The efficacy and safety of anti-PD-1/PD-L1 in treatment of glioma: a single-arm meta-analysis
    Zeng, Yi-Fan
    Wei, Xin-Yu
    Guo, Qi-Hao
    Chen, Si-Yu
    Deng, Sheng
    Liu, Zheng-Zheng
    Gong, Zhi-Cheng
    Zeng, Wen-Jing
    FRONTIERS IN IMMUNOLOGY, 2023, 14
12345